ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,753.70
0.35%
S&P ASX All Technology
3,050.50
0.56%
Brent Oil
82.705
0.19%
US Dollar vs AUD
1.49448
-1.01%
Bitcoin
65,904.20
7.08%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) News

HROW

Harrow (HROW)

Harrow Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HROW
DateTimeSourceHeadlineSymbolCompany
15/05/202421:00Business WireHarrow to Present at Two Investor Conferences in MayNASDAQ:HROWHarrow Inc
14/05/202406:01Business WireHarrow Announces First Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
13/05/202421:00Business WireHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialNASDAQ:HROWHarrow Inc
25/04/202421:00Business WireHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASDAQ:HROWHarrow Inc
02/04/202423:16Business WireMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingNASDAQ:HROWHarrow Inc
20/03/202422:15IH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:HROWHarrow Inc
20/03/202408:45Business WireHarrow Announces Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:HROWHarrow Inc
19/03/202422:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:HROWHarrow Inc
06/03/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
05/03/202423:00Business WireHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024NASDAQ:HROWHarrow Inc
22/02/202411:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
22/02/202411:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
16/02/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
16/02/202408:01Business WireHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical ProductsNASDAQ:HROWHarrow Inc
10/02/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HROWHarrow Inc
08/02/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
30/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
30/01/202407:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
29/01/202423:00Business WireHarrow Announces New Appointments to its Board of DirectorsNASDAQ:HROWHarrow Inc
11/01/202423:00Business WireHarrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye DiseaseNASDAQ:HROWHarrow Inc
10/01/202402:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
04/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
03/01/202423:15Business WireMelt Pharmaceuticals Provides Corporate UpdateNASDAQ:HROWHarrow Inc
03/01/202423:00Business WireHarrow Partners with Leading Healthcare Market Access Technology PlatformsNASDAQ:HROWHarrow Inc
29/11/202323:00Business WireHarrow Completes Transfer of the TRIESENCE® New Drug ApplicationNASDAQ:HROWHarrow Inc
20/11/202323:00Business WireHarrow to Present at Two Investor Conferences in NovemberNASDAQ:HROWHarrow Inc
17/11/202308:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
15/11/202311:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
14/11/202308:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HROWHarrow Inc
14/11/202308:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
 Showing the most relevant articles for your search:NASDAQ:HROW

Your Recent History

FX
AUDCAD
AUD vs CAD
ASX
CSL
CSL
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
ASX
BHP
BHP
NASDAQ
MSFT
Microsoft
ASX
WES
Wesfarmers
ASX
XTO
S&P ASX 100
NYSE
NKE
Nike
ASX
TLS
Telstra
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved